Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating expenses:
Research and development	$ 1,534,467	$ 1,699,845
General and administrative	1,393,808	1,200,728
Depreciation	27,020	18,272
Loss from operations	2,955,295	2,918,845
Other income:
Interest income	(34,100)	(20,684)
Loss from operations before income tax benefit	(2,921,195)	(2,898,161)
Income tax benefit	(362,380)	(150,352)
Net loss	$ (2,558,815)	$ (2,747,809)
Per share information:
Net loss per share of common stock, basic and diluted (in dollars per share)	$ (0.07)	$ (0.81)
Weighted average shares outstanding, basic and diluted (in dollars per share)	$ 34,507,496	$ 3,376,230